- ABOUT ME
- AREAS OF FOCUS
- EDUCATION & LEADERSHIP
- LOCATIONS & HOSPITALS
- NEWS & PUBLICATIONS
Dr. Debbie Cheng enjoys developing long-term, meaningful relationships with patients who live with chronic illnesses, such as inflammatory bowel disease (IBD). Dr. Cheng focuses on providing evidence-based care in a field that has interested her since medical school, and she has special interest in the impact gastrointestinal disease has on the normal functioning of the digestive system. Dr. Cheng feels honored to provide care, including by performing endoscopic procedures, to patients in both inpatient and outpatient settings.
Dr. Cheng focused her clinical training on inflammatory bowel disease during her gastroenterology fellowship. She was a faculty member at the Crohn’s Colitis Center at University of Colorado Anschutz Medical Center prior to joining The Oregon Clinic.
Outside of work, Dr. Cheng loves to get outside to go running, hiking, and biking, and exploring Oregon with her family, husband, and young child.
Other Activities
Member, American Gastroenterological Association (AGA)
Member, American College of Gastroenterology (ACG)
Areas of Focus
Inflammatory Bowel Disease
General Gastroenterology
EDUCATION & TRAINING
Fellowship, Gastroenterology and Hepatology, University of Pittsburgh Medical Center, 2021
Internal Medicine Residency, Clinical Scientist Track, University of Pittsburgh Medical Center, 2018
MD, University of Michigan Medical School, 2015
BS, Bioengineering, Summa Cum Laude, Member of Tau Beta Pi, University of Pennsylvania, 2010
BOARD CERTIFICATION
Gastroenterology
HONORS
ASGE LEAD Participant 2022
Cornerstones Health Best of DDW in IBD 2020 Fellow
Locations
Hospitals Served
- Legacy Good Samaritan Medical Center
- Legacy Mount Hood Medical Center
- Providence Portland Medical Center
- Providence Milwaukie Hospital
Publications
Galatowitsch, J., Haydek, J. P., Ahmed, W., Fennimore, B., Cheng, D., Steiner, C. A., … & Scott, F. I. (2022). S897 Ustekinumab Versus Tofacitinib as Second-Line Therapy for Ulcerative Colitis: A Retrospective, Observational Study. Official journal of the American College of Gastroenterology| ACG, 117(10S), e649-e651.
Anderson, A., Click, B., Ramos-Rivers, C., Cheng, D., Babichenko, D., Koutroubakis, I. E., … & Binion, D. G. (2017). Lasting impact of Clostridium difficile infection in inflammatory bowel disease: a propensity score matched analysis. Inflammatory bowel diseases, 23(12), 2180-2188.
Cheng, D. F., Anderson, A. J., Rivers, C. R., Click, B. H., Koutroubakis, I., Hashash, J. G., … & Binion, D. G. (2017). Variation in Annual Rate of Steroid Prescriptions Amongst Providers for Inflammatory Bowel Disease Patients is Dependent on Cohort Size and Disease Severity. Gastroenterology, 152(5), S792.
Cheng, D., Anderson, A., Ramos-Rivers, C., Click, B., Koutroumpakis, I., Hashash, J. G., … & Binion, D. (2016). Patterns Between Multi-Year Steroid Use in Patients with Inflammatory Bowel Disease and Quality of Life, Disease Severity, and Healthcare Utilization: 688. Official journal of the American College of Gastroenterology| ACG, 111, S312-S313.
Wei, I. H., Harmon, C. M., Arcerito, M., Cheng, D. F., Minter, R. M., & Simeone, D. M. (2014). Tumor-associated macrophages are a useful biomarker to predict recurrence after surgical resection of nonfunctional pancreatic neuroendocrine tumors. Annals of surgery, 260(6), 1088-1094.